Duvelisib attenuates bleomycin‐induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease that seriously threatens the health of patients. The pathogenesis of IPF is still unclear, and there is a lack of effective therapeutic drugs. Myofibroblasts are the main effector cells of IPF, leading to excessiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaohe, Ma, Xiaoyang, Miao, Yang, Zhang, Jianwei, Xi, Buri, Li, Wenqi, Zhang, Qianyi, Chen, Li, Yang, Yue, Li, Hongli, Wei, Luqing, Zhou, Honggang, Yang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889612/
https://www.ncbi.nlm.nih.gov/pubmed/36651446
http://dx.doi.org/10.1111/jcmm.17665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889612/
https://www.ncbi.nlm.nih.gov/pubmed/36651446
http://dx.doi.org/10.1111/jcmm.17665

Ejemplares similares